Clinical trial
Endovenous Chemical Ablation and Trendlenburg Operation for the Treatment of Great Saphenous Vein Varicosities
NCT05655416 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endovenous Chemical Ablation and Trendlenburg Operation for the Treatment of Great Saphenous Vein Varicosities
- Lead sponsor
- Al-Azhar University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2014
- Completion date
- April 5, 2021
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.